Pharmacogenetic Testing in Primary Care
Completed
Conditions studied: Pharmacogenetic Testing
In brief
The purpose of this study is to further integrate pharmacogenetic (PGx) testing into clinical practice by educating physicians about pharmacogenetics and offering testing to their patients. Pharmacogenetic testing may help physicians choose the best drug and dosage for their patients which can reduce side effects, increase effectiveness, and improve patient adherence. Two clinics will be involved. One clinic will have a pharmacist on-site as a resource to physicians and to advise what patients may benefit from PGx testing; the other clinic will have a pharmacist on call. Patient and physician perspectives about PGx testing and their utilization will be examined via surveys. The investigators hypothesize that with education about PGx testing, more physicians will utilize testing.
Key facts
- Study ID
- NCT01600846
- Run by
- Duke University
- People needed
- 400
- Starts
- 2012-12-01
- Expected to finish
- 2013-07-01
- Last updated by the study team
- 2017-07-28
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- must be a patient or physician at one of the participating clinics
- patients must be prescribed a medication that has PGx testing available
- 18 years of age or older
- English-speaking
Where it is running
- Duke University Medical Center — Durham, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.